Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Antitumour activity of coumarin in prostate and mammary cancer modelsE von Angerer, M Kager, A MaucherArchiv Der Pharmazie|August 1, 1990
Synthesis and biological properties of a 1-(6-aziridinylhexyl)-2-phenylindole, a potential fluorescence label for estrogen receptorsS Erber, H Birnböck, E von AngererEuropean Journal of Cancer & Clinical Oncology|April 1, 1985
The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumorsE von Angerer, J Prekajac, M BergerThe Journal of Steroid Biochemistry and Molecular Biology|July 1, 1996
Effect of growth factors on estrogen receptor mediated gene expressionF Hafner, E Holler, E von AngererArchiv Der Pharmazie|August 1, 1994
[3-Substituted 2-phenylindoles: synthesis and biological properties]S Mahboobi, G Grothus, E von AngererAnti-Cancer Drug Design|June 1, 1989
Platinum complexes with a selective action on estrogen receptor-positive mammary tumorsE von Angerer, H Birnböck, N KnebelAnti-Cancer Drug Design|November 1, 1991
2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cellsS Erber, R Ringshandl, E von AngererEndocrine Regulations|March 1, 1994
The activity of epitestosterone in hormone dependent prostate tumour modelsA Maucher, E von Angerer, R Hampl, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1992
The effect of a combination of zindoxifene and cisplatin on Dunning R3327-G prostatic carcinomas of the ratE von Angerer, H Birnböck, M Kager, et al.Archiv Der Pharmazie|October 1, 1991
[Antitumor platinum(II) complexes with substituted 2-aminomethylpyridine ligands]H Brunner, G Nerl, E von Angerer, et al.Pageof 7